Discipline Decisions (February 2026)

gavel

Decisions of the Discipline Committee between November 2025 and January 2026.


Maged Hanna (OCP #215337) 

At a hearing on October 17, 2025, a Panel of the Discipline Committee made findings of professional misconduct against Maged Hanna in that, while his certificate of registration was suspended, he: 

READ MORE

  • Worked at Disera Medical Pharmacy in Thornhill, Ontario (the “Pharmacy”); and
  • Held himself out as a pharmacist to patients and/or customers of the Pharmacy.  

In particular, the Panel found that the Registrant 

  • Failed to maintain a standard of practice of the profession;
  • Contravened section 143 of the Drug and Pharmacies Regulation Act
  • Failed to comply with an Order of a panel of the Discipline Committee; 
  • Practised the profession while his certificate of registration was under suspension; 
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional. 

The Panel imposed an Order, as follows: 

  1. A reprimand;
  2. Directing the Registrar to suspend the Registrant’s certificate of registration for a period of 9 months. The suspension shall commence on October 17, 2025, at the conclusion of the hearing and run without interruption until July 16, 2026, inclusive;
  3. Directing the Registrar to impose specified terms, conditions or limitations on the Registrant’s certificate of registration, including:
    1. The Registrant shall successfully complete, at his own expense, and within 9 months of the date of this Order, a bespoke remediation program with Gail E. Siskind Consulting Services or another ethics consultant approved by the College, focusing on the issues raised by the facts and findings of professional misconduct in this case. The remediation program shall include the following terms:
      1. Within 30-days of the decision in this matter, the Registrant shall retain the ethics consultant at his own expense;
      2. The ethics consultant and the Registrant shall meet for the purpose of remediation of the concerns raised by the facts and findings of professional misconduct in this case. The total number of sessions between the ethics consultant and the Registrant will be at the sole discretion of the ethics consultant, but shall be no less than 4;
      3. The Registrant shall provide the ethics consultant with the following documents related to this proceeding:
        1. a copy of the Agreed Statement of Facts;
        2. a copy of this Joint Submission on Order; and
        3. a copy of the Decision and Reasons of the Discipline Panel, when available.
      4. The Registrant shall develop a learning plan with the ethics consultant to comprehensively address the remediation required;
      5. The Registrant shall demonstrate to the ethics consultant that he has successfully achieved all of the goals of the learning plan. Successful completion of the learning plan includes, but is not limited to, an essay acceptable to the College, which shall address the professional misconduct issues arising in this case; and
      6. The essay shall be at least 1,000 words in length and the Registrant shall be responsible for the cost of the essay’s review by the ethics consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500; and
      7. The Registrant shall require the ethics consultant to report the results of the remediation program to the College within 12 months of the date of this Order. Such report shall include, but is not limited to, the ethics consultant’s assessment of the Registrant’s success in meeting the goals of the learning plan.
    2. The Registrant shall be prohibited from acting as the Designated Manager of any pharmacy for a period of 2 years from July 17, 2026;
    3. The Registrant shall be prohibited from having a proprietary interest in any pharmacy for a period of three years from October 17, 2025.
  4. Costs to the College in the amount of $20,000.

In its reprimand, the Panel noted that the Registrant’s actions undermined the College and the trust that members of the public place in the profession.  

The Panel indicated that this reprimand should serve as a clear warning that practicing while under suspension and disregarding the College’s authority will result in serious consequences. Future non-compliance may lead to more severe penalties, including revocation of registration.  

The Panel expressed its hope that the Registrant will not appear before a panel of the Discipline Committee again. 


Chi Luu (OCP #211624) 

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Chi Luu committed professional misconduct between in or about October 2021 and in or about May 2023, while engaged in the practice of pharmacy at Fort William Medical Pharmacy in Thunder Bay, Ontario, in that he: 

READ MORE

  • Submitted claims for payment to the Ontario Drug Benefit Program for MedsCheck services that were never conducted and/or were non-compliant with the requirements set forth by the Ministry of Health; 
  • Falsified records relating to MedsCheck services; and/or 
  • Failed to keep records and/or documentation as required for MedsCheck services.  

In particular, it is alleged that he: 

  • Failed to maintain a standard of practice of the profession; 
  • Failed to keep records as required respecting his patients and/or practice; 
  • Falsified a record relating to his practice and/or a person’s health record; 
  • Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement; 
  • Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading; 
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional. 

Mr. Lu entered into an Undertaking, Agreement and Acknowledgment while a discipline hearing into these allegations of professional misconduct against him was pending before the Discipline Committee, by which he agreed to: 

  • Permanently resign as a member of the College; 
  • No longer have any proprietary interest, direct or indirect, in any pharmacy; and 
  • Never work or be employed in a pharmacy in any capacity, including but not limited to volunteering. 

The College and Mr. Luu made a joint submission to the Discipline Committee to adjourn the hearing into this matter sine die. On the basis of the Undertaking, Agreement, and Acknowledgment, the Discipline Committee accepted the submissions of the parties and issued an order on November 10, 2025, adjourning this matter sine die


Jaspreet Sahota (OCP #613723) 

At a hearing on December 1, 2025, a Panel of the Discipline Committee made findings of professional misconduct against Jaspreet Sahota while engaged in the practice of pharmacy as owner, director, shareholder, Designated Manager, and/or pharmacist at Fort William Medical Pharmacy in Thunder Bay, Ontario, between in or about October 2021 and in or about May 2023, in that he:

READ MORE

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) claims for payment to the Ontario Drug Benefit Program for MedsCheck services that were never conducted and/or were non-compliant with the requirements set forth by the Ministry of Health;
  • Falsified (or permitted, consented to, or approved, expressly or by implication, the falsification of) records relating to MedsCheck services;  
  • Failed to (or permitted, consented to, or approved, expressly or by implication, the failure to) keep records and/or documentation as required for MedsCheck services; and/or 
  • Misappropriated and/or took drugs without authorization from the Pharmacy, including but not limited to controlled drugs and substances.: 

In particular, the Panel found that the Registrant: 

  • Failed to maintain a standard of practice of the profession; 
  • Failed to keep records as required respecting his patients and/or practice; 
  • Falsified a record relating to his practice and/or a person’s health record; 
  • Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement; 
  • Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional. 

The Panel imposed an Order, as follows: 

  1. A reprimand; 
  2. Directing the Registrar to suspend the Registrant’s certificate of registration for a period of 12 months. The suspension shall commence on February 22, 2026 and run without interruption until February 21, 2027, inclusive; 
  3. Directing the Registrar to impose specified terms, conditions or limitations on the Registrant’s certificate of registration, including: 
    1. The Registrant shall successfully complete within twelve months of the date of the Order, a course with Gail E. Siskind Consulting Services, or another professional ethics consultant approved by the College, to address the professional misconduct arising from this matter, to be designed by the consultant. The following terms shall apply to the course: 
      1. The number of sessions shall ultimately be at the discretion of the consultant, but shall consist of at least one meeting with the consultant; 
      2. The manner of attendance at the sessions (e.g., in person, via videoconference, etc.) is a matter to be discussed in advance between the Registrant and the consultant, but shall ultimately be at the discretion of the consultant; 
      3. The Registrant shall be responsible for the cost of the course; 
      4. The Registrant shall provide to the consultant the following documents, in advance of the course, to facilitate the design of the course: 
        1. A copy of the Notice of Hearing, the Agreed Statement of Facts, and this Joint Submission on Order; or 
        2. A copy of the Panel’s Decision and Reasons, once available; 
      5. Successful completion of the course shall be determined by the Consultant, based on the design of the course, but must include completion of an essay acceptable to the Registrar, which essay shall address the professional misconduct issues arising in this case; 
      6. The essay shall be at least 1,000 words in length and the Registrant shall be responsible for the cost of the essay’s review by the Consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500; and 
      7. The Registrant shall direct the Consultant to report the results of the course to the College, no later than 12 months from the date of this Order, and to confirm that the Registrant has completed the course to the satisfaction of the Consultant. 
    2. For a period of three years from the date of this Order, the Registrant shall be prohibited from having any proprietary interest in a pharmacy of any kind and/or receiving remuneration for his work as a pharmacist other than remuneration on an hourly or weekly basis; and 
    3. For a period of three years following the date the suspension in paragraph 2 of this Order ends, the Registrant: 
      1. shall be required to notify the College in writing of the names(s), address(s) and telephone numbers(s) of all employer(s) within seven days of commencing employment in a pharmacy, including employment as a relief pharmacist or other short-term employment; 
      2. shall provide any pharmacy employer with a copy of the Discipline Committee Panel’s decision in this matter and its Order; and 
      3. shall only engage in the practice of pharmacy for an employer who agrees to write to the College within seven days of the Registrant commencing employment, confirming that it has received a copy of the required documents identified in subparagraph 3(c)(ii) and confirming the nature of the Registrant’s remuneration. 
  4. Costs to the College in the amount of $10,000. 

In its reprimand, the Panel noted that the Registrant engaged in several acts of professional misconduct. As a pharmacist, he is entrusted with the responsibility to uphold the highest standards of integrity, professionalism, and ethical conduct. His conduct demonstrated a serious and persistent disregard for these obligations. 

The Panel pointed out that the submission of false claims undermines the integrity of the pharmacy profession and erodes public confidence and safety, and the misappropriation of controlled substances constitutes a grave breach of both professional and legal standards. 

As a member of this profession, the Registrant is expected to act with honesty, transparency, and accountability at all times. He failed in this regard. 

The Panel indicated that the Registrant’s conduct not only brought shame to himself, but to the profession of pharmacy as a whole, and that it was dismayed by the fact that this was the Registrant’s second appearance before the Discipline Committee. 

The Panel observed that the Order contains important remediation and rehabilitation measures. The Registrant must take these measures seriously, learn from them, and apply them to his practice. The Panel expressed its hope that the Registrant will learn from this experience, and its expectation that he will not appear again before this Discipline Committee. 


Haytham Youssef (OCP #623129) 

At a hearing on January 30, 2026, a Panel of the Discipline Committee made findings of professional misconduct against Haytham Youssef, while engaged in the practice of pharmacy as a dispensing pharmacist at Shoppers Drug Mart in Hamilton, Ontario, (“the Pharmacy”), in that he: 

READ MORE

  • Dispensed a Schedule I drug, namely Mounjaro, to himself purportedly authorized by Physician A where no such authorization was given;
  • Falsified records of authorizations from Physician A on prescriptions for a Schedule I drug, namely Mounjaro dispensed to himself;
  • Dispensed a Schedule I drug, namely Mounjaro, to himself in contravention of the College’s Policy on Treating Self and Family Members

In particular, the Panel found that the Registrant: 

  • Failed to maintain a standard of practice of the profession; 
  • Practiced the profession while he was in a conflict of interest; 
  • Failed to keep records as required respecting his patients or practice; 
  • Falsified a record relating to his practice or a person’s health record; 
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known was false or misleading; 
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular: s. 155(1) of the Drug and Pharmacies Regulation Act, RSO 1990, c. H. 4; 
  • Contravened any federal, provincial, or territorial law or municipal by-law, with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health, or that is otherwise relevant to the member’s suitability to practice, and in particular: s. C.01.041 of the Food and Drug Regulations (CRC c.870);
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as unprofessional. 

The Panel imposed an Order, as follows: 

  1. A reprimand; 
  2. That the Registrar is directed to impose specified terms, conditions or limitations on the Registrant’s Certificate of Registration, and in particular: 
    1. The Registrant shall successfully complete, at his own expense and within 12 months of the date of the Order, the ProBE Program on Professional/Problem Based Ethics for Heath Care Professionals with an unconditional pass; 
    2. For one year commencing on January 30th, 2026, the Registrant shall: 
      1. notify the College in writing of the name, address, and telephone number of any current or future employer, within fourteen (14) days of resuming any current employment or commencing any future employment in pharmacy; 
      2. provide his employer(s) in pharmacy with: 
        1. a copy of the Agreed Statement of Facts and this Joint Submission on Order, or 
        2. the Decision and Reasons of the Discipline Committee in this matter, including this Order (when available), 
          prior to resuming any current employment or commencing any future employment in pharmacy; 
      3. only engage in the practice of pharmacy for an employer who agrees to advise the College in writing, within fourteen (14) days of the Registrant resuming any current employment or commencing any new employment with the employer, confirming that the Designated Manager of the employer’s pharmacy has received a copy of the documents set out in paragraph 2(b)(ii) above; 
  3. That the Registrar suspend the Registrant’s Certificate of Registration for a period of three months. The suspension shall commence on January 30th, 2026, and shall continue until April 29th, 2026, inclusive. 
  4. Costs to the College in the amount of $10,000. 

In its reprimand, the Panel noted that the Registrant is a pharmacist and a member of a highly regarded profession within the healthcare system. Integrity, professionalism, and ethical conduct are foundational principles for those who practice this profession. 

The Panel indicated that the Registrant failed in his role as a pharmacist. As an experienced pharmacist, with years of practice behind him, he should have known better. 

The Panel observed that practicing pharmacy is a privilege involving significant obligations that are owed to patients, the profession, and oneself. The Panel explained that the Registrant must change his ways and expressed its hope that he has learned from this experience, will remediate his practice in accordance with the Order, and will never again appear before a Panel of this Discipline Committee.


Alice Rusli (OCP #606094) 

Following a hearing held on November 22, 23, 24, 25, 30, 2021; December 14, 16 2021; and April 5 and 25, 2022, a Panel of the Discipline Committee made findings of professional misconduct in a decision dated June 28, 2023, against Alice Rusli, in her role as pharmacist, Designated Manager and/or shareholder at Glen Shields Pharmacy, with respect to the Pharmacy’s system and practices for obtaining veterinary drugs and/or products from [Wholesaler] through [Animal Hospital], including but not limited to in or around March 2019 through June 2019. 

READ MORE

In particular, the Panel found that the Registrant: 

  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement; 
  • Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, and in particular section 33(2)(d) of the General Regulation, R.R.O. 1990, Regulation 1093, under the Veterinarians Act, R.S.O. 1990, c. V.3;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as unprofessional. 

Following submissions with respect to the order to be imposed on April 15, 16, and 22, 2024, the Panel imposed an Order as follows in a decision dated November 20, 2024: 

  1. A reprimand; 
  2. An Order directing the Registrar to suspend the Registrant’s Certificate of Registration for a period of four (4) months, with one (1) month of the suspension to be remitted on the condition that the Registrant completes the courses specified in subparagraphs 3(a) and (b) below. The first three (3) months of this suspension shall commence on the date when this Order becomes final and shall continue without interruption. If the remitted portion of the suspension is required to be served by the Registrant because she fails to complete the courses specified in subparagraphs 3(a) and (b) below, that portion of the suspension shall commence on the date that is twelve (12) months after the date when this Order becomes final. If the time for completing the course in subparagraph 3(a) and/or (b) is extended by the Registrar, then the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.  
  3. An Order directing the Registrar to impose specified terms, conditions and limitations on the Registrant’s Certificate of Registration, as follows: 
    1. the Registrant shall successfully complete, at her own expense, the College’s Jurisprudence e-Learning Modules and Jurisprudence Exam, within twelve (12) months of the date when this Order becomes final; 
    2. the Registrant shall successfully complete, at her own expense, the ProBE Program on Professional/Problem-Based Ethics for healthcare professionals offered by the Center for Personalized Education for Physicians (CPEP), with an unconditional pass, within twelve (12) months of the date when this Order becomes final; 
    3. for a period of three (3) years beginning on the date when this Order becomes final, the Registrant shall be prohibited from acting as a Designated Manager at any pharmacy; 
    4. for a period of three (3) years beginning on the date when this Order becomes final, the Registrant shall be prohibited from acting as a director or voting as a shareholder in any corporation operating a pharmacy; and 
    5. for a period of one (1) year beginning on the date that the Registrant returns to practice as a Designated Manager and/or becomes a director or voting shareholder in the operation of any pharmacy in which she has any proprietary interest, shall be subject to Compliance Audit Reviews (“CARs”) by the College. The following terms apply to the CARs: 
      1. the College will be entitled to conduct any CAR for a period of one (1) year commencing on the date that the Registrant returns to practice as a Designated Manager and/or becomes a director or voting shareholder (“CARs Period”); 
      2. if the Registrant ceases practice as a Designated Manager and/or to have a proprietary interest in any pharmacy at any time within the one (1) year specified in subparagraph (i) above, such that the College is unable to conduct any CARs, then the CARs Period shall be paused and shall resume on the date on which the Registrant returns to practice as a Designated Manager and/or to have a proprietary interest in a pharmacy, and in such circumstances: 
        1. the Registrant shall notify the College, in writing, if she is no longer a Designated Manager and/or has a proprietary interest in a pharmacy at any point(s) during any times that the CARs Period remains active; and 
        2. if the CARs Period is paused at any time(s), the Registrant shall notify the College, in writing, when she returns to practice as a Designated Manager and/or has a proprietary interest in a pharmacy, at which point the CARs period shall resume and shall continue until a total period of one (1) year has been completed;  
      3. the CARs will be conducted by means of attendances, either in person or virtual, by a representative of the College at the Registrant’s place of practice as a Designated Manager and/or at any pharmacy in which she holds any proprietary interest, at such times as the College may determine; 
      4. during any CAR, the College representative will be entitled to review and examine the Registrant’s practice, or the practice and operation of any pharmacy in which the Registrant holds any proprietary interest, with respect to compliance with legislation and regulations; 
      5. the CARs are in addition to any routine inspections conducted by the College pursuant to the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4., and are not a substitute for such inspections; 
      6. the Registrant shall fully cooperate with the College representative during the CARs; and 
      7. the Registrant shall pay to the College in respect of such CAR the amount of one thousand dollars ($1000.00) per CAR, immediately after each CAR is completed, with the total amount to be paid by the Registrant not to exceed two thousand dollars ($2000.00), regardless of the number of CARs and/or attendances conducted by the College. 
  4. Costs to the College in the amount of $137,000.00.

The reprimand in this matter remains outstanding. 

The full text of these decisions will be available at www.canlii.org.

CanLii is a non-profit organization managed by the Federation of Law Societies of Canada. CanLii’s goal is to make Canadian law accessible for free on the Internet.